3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
CNS
1
Conditions
Pain
9
Neoplasms
4
Cancer Pain
4
Agnosia
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuralgia
2
Multiple Myeloma
2
Lymphoma
2
Inflammation
2
Head and Neck Neoplasms
2
Acute Pain
2
Waldenstrom Macroglobulinemia
1
Urinary Tract Infections
1
Trigger Finger Disorder
1
Thrombocythemia, Essential
1
Stomatitis
1
Staphylococcal Infections
1
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
1
Squamous Cell Carcinoma of Head and Neck
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sezary Syndrome
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Interventions
Nutrition Assessment
4
Bevacizumab
3
Lisinopril
2
Labetalol
2
Hydrochlorothiazide
2
Angiotensin-Converting Enzyme Inhibitors
2
ziprasidone
1
pazopanib
1
ganirelix
1
enzalutamide
1
clevidipine
1
bicalutamide
1
benazepril
1
aliskiren
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Urine Specimen Collection
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Standard of Care
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hypertension
×
Oxycodone
×
Clear all
NCT01431326
2023-09-06
PTN_POPS
Duke University
Completed
3,520 enrolled